• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

1.710 -0.010 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,700
Open 1.760
Bid (Size) 1.660 (100)
Ask (Size) 1.700 (900)
Prev. Close 1.720
Today's Range 1.690 - 1.795
52wk Range 1.260 - 39.25
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients
March 12, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients
March 12, 2026
Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable... 
Via TheNewswire.com

Performance

YTD
-67.0%
-67.0%
1 Month
+8.2%
+8.2%
3 Month
-79.5%
-79.5%
6 Month
-90.0%
-90.0%
1 Year
-95.4%
-95.4%

More News

Read More
GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine
March 11, 2026
Via TheNewswire.com
News headline image
GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine
March 11, 2026
Via NewMediaWire
News headline image
GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors
February 24, 2026
Via NewMediaWire
GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors
February 24, 2026
Via TheNewswire.com
GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology
February 18, 2026
Via TheNewswire.com
Topics Intellectual Property
News headline image
GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology
February 18, 2026
Via NewMediaWire
Topics Intellectual Property
News headline image
GeoVax Endorses Global Call to Sustain Mpox Response as Evidence Confirms Epidemic Is Far From Over
February 17, 2026
Via NewMediaWire
GeoVax Endorses Global Call to Sustain Mpox Response as Evidence Confirms Epidemic Is Far From Over
February 17, 2026
Via TheNewswire.com
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 13, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
February 13, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
February 13, 2026
Via Chartmill
News headline image
GeoVax Labs Announces $1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
February 13, 2026
Via NewMediaWire
Topics Regulatory Compliance
GeoVax Labs Announces $1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
February 13, 2026
Via TheNewswire.com
Topics Regulatory Compliance
News headline image
GeoVax Highlights 2026 as a Pivotal Year for Progress
January 20, 2026
Via NewMediaWire
GeoVax Highlights 2026 as a Pivotal Year for Progress
January 20, 2026
Via TheNewswire.com
Friday's pre-market session: top gainers and losers ↗
January 09, 2026
Via Chartmill
News headline image
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
January 08, 2026
Via NewMediaWire
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
January 08, 2026
Via TheNewswire.com
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week
January 06, 2026
Via TheNewswire.com
News headline image
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week
January 06, 2026
Via NewMediaWire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
January 02, 2026
Via Chartmill
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
December 24, 2025
Via Chartmill
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
December 23, 2025
Via Chartmill

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 1.710
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 03/16/26 04:00 PM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 3.71M
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap